Association of nuclear hnRNPD with poor prognosis in OSCC patients taken together with its associated protein networks in oral cancer warrant future studies designed to explore its potential as a plausible novel target for molecular therapeutics. The gene discussed is HNRNPD; the disease is lip and oral cavity carcinoma.